Managing distorted ABSORB Scaffold in left main during anomalous LMCA stenting

Pratap Chandra Rath; Krupal C Reddy; Manoj K Agarwala; Bharat V Purohit

doi:10.1016/j.ihj.2015.02.022

Managing distorted ABSORB Scaffold in left main during anomalous LMCA stenting

Indian Heart J. 2015 May-Jun;67(3):268-70. doi: 10.1016/j.ihj.2015.02.022. Epub 2015 Mar 11.

Authors

Pratap Chandra Rath¹, Krupal C Reddy², Manoj K Agarwala³, Bharat V Purohit²

Affiliations

¹ Director of Cath Lab, Senior Interventional Cardiologist, Apollo Health City, Jubilee Hills, Hyderabad, India. Electronic address: [email protected].
² Consultant Cardiologist, Apollo Health City, Jubilee Hills, Hyderabad, India.
³ Senior Interventional Cardiologist, Apollo Health City, Jubilee Hills, Hyderabad, India.

Abstract

The everolimus-eluting biovascular scaffold (BVS) does not contain any metal, therefore struts are not evident angiographically. Two adjacent platinum radio-opaque markers at each end facilitate precise location of stent ends. Here we report one case of anomalous left main stenting using BVS. The BVS got accidentally distorted in left main during the procedure, which was not visible on angiography but detected on OCT.

Keywords: ABSORB scaffold; Anomalous left main coronary artery; LMCA stenting; Optical coherence tomography; Percutaneous coronary stenting.

Publication types

Case Reports

MeSH terms

Absorbable Implants*
Anterior Wall Myocardial Infarction / diagnosis
Anterior Wall Myocardial Infarction / etiology
Anterior Wall Myocardial Infarction / surgery*
Coronary Angiography
Coronary Vessel Anomalies / complications*
Coronary Vessel Anomalies / diagnosis
Coronary Vessel Anomalies / surgery
Coronary Vessels / diagnostic imaging
Coronary Vessels / surgery
Drug-Eluting Stents*
Everolimus / pharmacology*
Humans
Immunosuppressive Agents / pharmacology
Male
Middle Aged
Percutaneous Coronary Intervention / methods*
Prosthesis Design
Tissue Scaffolds*
Tomography, Optical Coherence

Substances

Immunosuppressive Agents
Everolimus